[{"address1": "Maxim 1", "address2": "2 Parklands Way Holytown", "city": "Motherwell", "zip": "ML1 4WR", "country": "United Kingdom", "phone": "44 14 1433 7557", "website": "https://tcbiopharm.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bryan Leland Kobel", "age": 44, "title": "CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 544560, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin Edward Thorp", "age": 71, "title": "CFO & Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 410521, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Camarra", "title": "Executive Vice President of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lauren  Bor Ph.D.", "title": "Head of Commercial Development Division", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.6, "open": 2.59, "dayLow": 2.15, "dayHigh": 2.6, "regularMarketPreviousClose": 2.6, "regularMarketOpen": 2.59, "regularMarketDayLow": 2.15, "regularMarketDayHigh": 2.6, "beta": 0.107, "forwardPE": -0.4782609, "volume": 863010, "regularMarketVolume": 863010, "averageVolume": 511618, "averageVolume10days": 1784750, "averageDailyVolume10Day": 1784750, "marketCap": 1258446, "fiftyTwoWeekLow": 1.89, "fiftyTwoWeekHigh": 1140.0, "fiftyDayAverage": 5.33022, "twoHundredDayAverage": 10.55403, "currency": "USD", "enterpriseValue": 218332896, "floatShares": 98445670, "sharesOutstanding": 572021, "sharesShort": 19179, "sharesShortPriorMonth": 68495, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.0335, "heldPercentInsiders": 6.0000002e-05, "heldPercentInstitutions": 0.033010002, "shortRatio": 0.05, "shortPercentOfFloat": 0.035, "bookValue": 3.382, "priceToBook": 0.6505027, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -8593896, "trailingEps": -197.32, "forwardEps": -4.6, "enterpriseToEbitda": -16.894, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "TCBP", "underlyingSymbol": "TCBP", "shortName": "TC BioPharm (Holdings) plc", "longName": "TC Biopharm (Holdings) Plc", "firstTradeDateEpochUtc": 1644589800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ef544858-646b-3e8d-bcb0-2aed3539a593", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.2, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 980955, "totalCashPerShare": 0.01, "ebitda": -12923699, "totalDebt": 1728127, "quickRatio": 0.459, "currentRatio": 0.882, "debtToEquity": 159.939, "returnOnAssets": -1.08915, "returnOnEquity": -12.1748, "freeCashflow": -6853025, "operatingCashflow": -10042216, "financialCurrency": "GBP", "trailingPegRatio": null, "__fetch_time": "2024-10-24"}]